Cargando…
Multi-omics profiling: the way toward precision medicine in metabolic diseases
Metabolic diseases including type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and metabolic syndrome (MetS) are alarming health burdens around the world, while therapies for these diseases are far from satisfying as their etiologies are not completely clear yet. T2DM, NAFL...
Autores principales: | Hu, Cheng, Jia, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697344/ https://www.ncbi.nlm.nih.gov/pubmed/34406397 http://dx.doi.org/10.1093/jmcb/mjab051 |
Ejemplares similares
-
Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
por: Finotello, Francesca, et al.
Publicado: (2018) -
Multi-omics approach to precision medicine for immune-mediated diseases
por: Ota, Mineto, et al.
Publicado: (2021) -
Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
por: Ovejero, Sara, et al.
Publicado: (2021) -
Integrating Rehabilomics into the Multi-Omics Approach in the Management of Multiple Sclerosis: The Way for Precision Medicine?
por: Bonnechère, Bruno
Publicado: (2022) -
Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine
por: Antonatos, Charalabos, et al.
Publicado: (2023)